Nothing Special   »   [go: up one dir, main page]

Poupart, 2020 - Google Patents

Synthesis, diversification and biomedical applications of 4, 5-substitued N-aminoimidazol-2-ones

Poupart, 2020

View PDF
Document ID
4132654921154672614
Author
Poupart J
Publication year

External Links

Snippet

In peptide-based medicinal chemistry, mimicry of turn conformations is important because of the significance of such secondary structures for molecular recognition. In this context, N- aminoimidazol-2-one (Nai) residues have demonstrated ability to mimic the central residue …
Continue reading at papyrus.bib.umontreal.ca (PDF) (other versions)

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/50—Cyclic peptides containing at least one abnormal peptide link
    • C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
    • C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
    • C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64—Cyclic peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/04—Linear peptides containing only normal peptide links
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00—Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06—Esters of carbamic acids
    • C07C271/08—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10—Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D205/00—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom
    • C07D205/02—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D205/04—Heterocyclic compounds containing four-membered rings with one nitrogen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members

Similar Documents

Publication Publication Date Title
TWI423987B (en) Cyclic peptide cxcr4 antagonists
Seebach et al. γ2‐, γ3‐, and γ2, 3, 4‐Amino acids, coupling to γ‐hexapeptides: CD spectra, NMR solution and X‐ray crystal structures of γ‐peptides
US5719296A (en) Pseudopeptide lactam inhibitors of peptide binding to MHC class II proteins
Jamieson et al. Positional scanning for peptide secondary structure by systematic solid-phase synthesis of amino lactam peptides
Cai et al. Biological and conformational study of β‐substituted prolines in MT‐II template: steric effects leading to human MC5 receptor selectivity
Mir et al. Paired utility of aza-amino acyl proline and indolizidinone amino acid residues for peptide mimicry: conception of prostaglandin F2α receptor allosteric modulators that delay preterm birth
CN111447941A (en) Polypeptide conjugates for intracellular delivery of binding peptides
Doan et al. Solid‐phase synthesis of C‐terminal azapeptides
KR20240000510A (en) Sortilin activity modulator
Colarusso et al. Optimization of linear and cyclic peptide inhibitors of KEAP1-NRF2 protein-protein interaction
WO1997016425A1 (en) Novel inhibitors of peptide binding to mhc class ii proteins
JP2003511447A (en) Substituted diazepanes
Fang et al. Design, synthesis, and opioid activity of arodyn analogs cyclized by ring-closing metathesis involving Tyr (allyl)
Bourguet et al. Benzophenone semicarbazone protection strategy for synthesis of aza‐glycine containing aza‐peptides
Petrov et al. Synthesis and evaluation of 3-aminopropionyl substituted fentanyl analogues for opioid activity
Banfi et al. Synthesis and biological evaluation of new conformationally biased integrin ligands based on a tetrahydroazoninone scaffold
Poupart Synthesis, diversification and biomedical applications of 4, 5-substitued N-aminoimidazol-2-ones
US5817757A (en) Inhibitors of peptide binding to MHO class II proteins
De Wachter et al. Influence of ring substitution on the conformation and β-turn mimicry of 4-amino-1, 2, 4, 5-tetrahydro-2-benzazepin-3-one peptide mimetics
Galaud et al. Homoserine‐derived cyclic sulfamidate as chiral educt for the diversity‐oriented synthesis of lactam‐bridged dipeptides
JP4361679B2 (en) Echinocandin derivatives, processes for their preparation and their use as antifungal agents
Kobayakawa et al. Chloroalkene dipeptide isosteres as peptidomimetics
WO1997016410A1 (en) Novel inhibitors of peptide binding to mhc class ii proteins
Ferron et al. Design and scalable synthesis of new chiral selectors. Part 1: Synthesis and characterization of a new constrained cyclopeptide from unnatural bulky amino acids
US8993515B2 (en) Peptidomimetics comprising N-amino cyclic urea residues and uses thereof